ICYMI, some of the content featured this week includes a new podcast episode and stories on finasteride, telehealth, medical device company acquisitions, updates in acne research, plus more.
In case you missed it, some of this week’s featured content includes a new podcast episode about building a COVID-19 dermatology registry, as well as stories on finasteride risks for younger males, how COVID-19 telehealth helps broaden patient population, updates in acne research, plans for Allergan Aesthetics to acquire a medical device company, plus more.
This week’s edition of The Mainstream Patient features stories on acne treatment alternatives, dermal fillers, skincare regimens for psoriasis, wet hair care, laser treatments, plus more.
A recent study shows an association between finasteride use and psychological adverse events (AEs) including suicidality. Dermatologists should weigh benefits and risks carefully when considering finasteride for certain patients with hair loss, according to one expert
A retrospective study shows significant differences in the characteristics of patients seen by telehealth during the COVID-19 pandemic versus those seen during in-office visits 1 year earlier.
Topicals and oral antibiotics, as well as research on the skin microbiome, are paving the way for the future of acne treatment, according to a recent presentation at the 2020 ODAC Pre-Conference Inflammatory Diseases Symposium.
Allergan Aesthetics has entered into a warrant agreement that will give the company an option to acquire Cypris Medical following the completion of a clinical trial evaluating Cypris’ Xact device.
Esther Freeman, MD, PhD, details how her and her fellow colleagues banded together to create a COVID-19 dermatology registry in just eight days. The registry has since seen over 1,000 submissions from frontline clinicians located in 40 countries, helping to identify and diagnose active COVID-19 through submitted skin findings.
Acne research delineating molecular and cellular pathogenic pathways gives insight into new therapeutic targets. According to a recent review, biologics and other therapies that modulate scar formation and wound healing will have value for treating severe acne.